益盛药业
(002566)
| 流通市值：14.16亿 | | | 总市值：20.19亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 435,332,238.54 | 338,483,583.1 | 178,610,348.46 | 640,173,748.36 |
| 营业总成本 | 424,179,798.67 | 327,911,771.13 | 171,901,860.11 | 627,180,152.74 |
| 其他经营收益 | | | | |
| 营业利润 | 21,526,277.76 | 32,290,535.2 | 18,904,312.47 | 31,315,053.18 |
| 利润总额 | 21,254,127.38 | 32,132,571.67 | 18,903,643.31 | 30,060,539.15 |
| 净利润 | 20,583,406.21 | 27,828,590.67 | 16,223,155.68 | 28,930,178.16 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 20,583,406.21 | 27,828,590.67 | 16,223,155.68 | 28,930,178.16 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,431,569,772.57 | 2,448,653,179.22 | 2,454,062,775.35 | 2,397,803,382.86 |
| 非流动资产: | | | | |
| 非流动资产合计 | 539,087,453.4 | 545,532,574.33 | 552,158,570.46 | 561,818,235.7 |
| 资产总计 | 2,970,657,225.97 | 2,994,185,753.55 | 3,006,221,345.81 | 2,959,621,618.56 |
| 流动负债: | | | | |
| 流动负债合计 | 406,025,908.95 | 422,165,438.43 | 418,511,324.16 | 384,103,658.96 |
| 非流动负债: | | | | |
| 非流动负债合计 | 241,254,625.05 | 241,398,438.69 | 242,217,452.21 | 246,248,545.84 |
| 负债合计 | 647,280,534 | 663,563,877.12 | 660,728,776.37 | 630,352,204.8 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,226,274,650.9 | 2,231,865,761.27 | 2,247,655,068 | 2,231,510,780.79 |
| 股东权益合计 | 2,323,376,691.97 | 2,330,621,876.43 | 2,345,492,569.44 | 2,329,269,413.76 |
| 负债和股东权益合计 | 2,970,657,225.97 | 2,994,185,753.55 | 3,006,221,345.81 | 2,959,621,618.56 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 481,736,948.53 | 389,198,040.76 | 212,095,103.14 | 738,443,064.55 |
| 经营活动现金流出小计 | 451,015,139.31 | 349,124,682.33 | 180,492,697.26 | 639,703,450.7 |
| 经营活动产生的现金流量净额 | 30,721,809.22 | 40,073,358.43 | 31,602,405.88 | 98,739,613.85 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 515,151,207.97 | 463,495,005.87 | 162,999,228.69 | 463,290,303.91 |
| 投资活动现金流出小计 | 522,002,163.1 | 481,707,373.81 | 51,195,665.22 | 516,706,069.16 |
| 投资活动产生的现金流量净额 | -6,850,955.13 | -18,212,367.94 | 111,803,563.47 | -53,415,765.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 347,400,000 | 347,400,000 | 217,400,000 | 353,000,000 |
| 筹资活动现金流出小计 | 349,688,541.97 | 346,654,534.13 | 189,994,278.44 | 406,249,544.26 |
| 筹资活动产生的现金流量净额 | -2,288,541.97 | 745,465.87 | 27,405,721.56 | -53,249,544.26 |
| 汇率变动对现金及现金等价物的影响 | -0.11 | -0.08 | -0.04 | 164.38 |
| 现金及现金等价物净增加额 | 21,582,312.01 | 22,606,456.28 | 170,811,690.87 | -7,925,531.28 |
| 期末现金及现金等价物余额 | 85,136,621.92 | 86,160,766.19 | 234,366,000.78 | 63,554,309.91 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 22,606,456.28 | - | -7,925,531.28 |